Related Articles
Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine
Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer
Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition